Piceatannol inhibits mast cell-mediated allergic inflammation

International Journal of Molecular Medicine

Volumn 31, Issue 4, 2013, Pages 951-958

  Ko, Yu Jin ^a   Kim, Hui Hun ^a   Kim, Eun Jung ^a   Katakura, Yoshinori ^b   Lee, Won Sup ^c   Kim, Gon Sup ^c   Ryu, Chung Ho ^a,d  

^a Gyeongsang National University   (South Korea)

^b KYUSHU UNIVERSITY   (Japan)

^c Gyeongsang National University School of Medicine   (South Korea)

^d Gyeongsang National University   (South Korea)

Author keywords

Allergic inflammation; Cytokine; MAP kinase; Mast cells; Piceatannol

Indexed keywords

ANTIALLERGIC AGENT; ANTIINFLAMMATORY AGENT; BETA N ACETYLHEXOSAMINIDASE; HISTAMINE; IMMUNOGLOBULIN E; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PICEATANNOL; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

ALLERGY; ANAPHYLAXIS; ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CYTOKINE RELEASE; HUMAN; HUMAN CELL; MALE; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT;

ANAPHYLAXIS; ANIMALS; ANTI-INFLAMMATORY AGENTS; BETA-N-ACETYLHEXOSAMINIDASES; CELL LINE; CELL SURVIVAL; CYTOKINES; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HISTAMINE; HUMANS; MALE; MAST CELLS; MICE; MICE, INBRED ICR; P-METHOXY-N-METHYLPHENETHYLAMINE; SIGNAL TRANSDUCTION; STILBENES;

EID: 84875251054     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2013.1283     Document Type: Article

References (39)

1. Bhat KPL, Kosmeder JW II and Pezzuto JM: Biological effects of resveratrol. Antiox Redox Signal 3: 1041-1064, 2001.
2. ElAttar TM and Virji AS: Modulating effect of resveratrol and quercetin on oral cancer cell growth and proliferation. Anticancer Drugs 10: 187-193, 1999.
3. Kawada N, Seki S, Inoue M and Kuroki T: Effect of antioxidants, resverarol, quercetin, and N-acetylcysteine, on the functions of cultured rat hepatic stellate cells and Kupffer cells. J Hepatol 27: 1265-1274, 1998.
4. Wadsworth TL and Koop DR: Effect of wine polyphenolic quercetin and resveratrol on pro-inflammatory cytokine expression in RAW 264.7 macrophages. Biochem Pharmacol 57: 941-949, 1999.
5. Martinez J and Moreno JJ: Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production. Biochem Pharmacol 59: 865-870, 2000.
6. Ferrigni NR, McLaughlin JL, Powell RG and Smith CR Jr: Use of potato disc and brine shrimp bioassays to detect activity and isolate piceatannol as the antileukemic principle from the seeds of Euphorbia lagascae. J Nat Prod 47: 347-352, 1984.
7. Wieder T, Prokop A, Bagci B, et al: Piceatannol, a hydroxylated analog of the chemopreventive agent resveratrol, is a potent inducer of apoptosis in the lymphoma cell line BJAB and in primary, leukemic lymphoblasts. Leukemia 15: 1735-1742, 2001.
8. Geahlen RL and McLaughlin JL: Piceatannol (3,4,3′,5′- tetrahydroxy-trans-stilbene) is a naturally occurring protein-tyrosine kinase inhibitor. Biochem Biophys Res Commun 165: 241-245, 1989.
9. Cheong H, Ryu SY and Kim KM: Anti-allergic action of resveratrol and related hydroxystilbenes. Planta Med 65: 266-274, 1999.
10. Shishodia S and Aggarwal BB: Nuclear factor-kappaB activation: a question of life or death. J Biochem Mol Biol 35: 28-40, 2002.
11. Thakkar K, Geahlen RL and Cushman M: Synthesis and protein tyrosine kinase inhibitory activity of polyhydroxylated stilbene analogues of piceatannol. J Med Chem 36: 2950-2955, 1993.
12. Wang BH, Lu ZX and Polya GM: Inhibition of eukaryote serine/threonine- specific protein kinases by piceatannol. Planta Med 64: 195-159, 1998.
13. Oliver JM, Burg DL, Wilson BS, McLaughlin JL and Geahlen RL: Inhibition of mast cell FcR1-mediated signaling and effector function by the syk selective inhibitor, Piceatannol. J Biol Chem 269: 296-297, 1994.
14. Tsai SK, Hung LM, Fu YT, et al: Resveratrol neuroprotective effects during focal cerebral ischemia injury via nitric oxide mechanism in rats. J Vasc Surg 46: 346-353, 2007.
15. Rocha-Gronzǎlez HI, Ambriz-Tututi M and Granados-Soto V: Resveratrol: A natural compound with pharmacological potential in neurodegenerative diseases. CNS Neurosci Ther 14: 234-247, 2008.
16. Zhu Z, Homer RJ, Wang Z, et al: Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 103: 779-788, 1999.
17. Royer B, Varadaradjalou S, Saas P, et al: Autocrine regulation of cord blood-derived human mast cell activation by IL-10. J Allergy Clin Immunol 108: 80-86, 2001.
18. Stassen M, Müller C, Arnold M, et al: IL-9 and IL-13 production by activation mast cells is strongly enhanced in the presence of lipopolysaccharide: NF-kappa B is decisively involved in the expression of IL-9. J Immunol 166: 4391-4398, 2001.
19. Barmes PJ and Adcock I: Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol Sci 14: 436-441, 1993.
20. Mukaida N: Interleukin-8: an expanding universe beyond neutrophil chemotaxis and activation. Int J Hematol 72: 391-398, 2000.
21. Rasmussen H and Goodman DB: Relationships between calcium and cyclic nucleotides in cell activation. Physiol Rev 57: 421-509, 1977.
22. White JR, Pluznik DH, Ishizaka K and Ishizaka T: Antigen-induced increase in protein kinase C activity in plasma membranes of mast cells. Proc Natl Acad Sci USA 82: 8193-8197, 1985.
23. 2+ induced IL-8 production in human mast cells. Cytokine 32: 226-233, 2005.
24. Kim SH, Kwon TK and Shin TY: Antiallergic effects of Vitis amurensis on mast cell-mediated allergy model. Exp Biol Med 233: 192-199, 2008.
25. Kim SH, Park SB, Kang SM, et al: Anti-allergic effects of Teucrium japonicum on mast cell-mediated allergy model. Food Chem Toxicol 47: 398-403, 2009.
26. Kim SH, Lee S, Kim IK, et al: Suppression of mast cell-mediated allergic reaction by Amomum xanthiodes. Food Chem Toxicol 45: 2138-2144, 2007.
27. Kang OH, Jang HJ, Chae HS, et al: Anti-inflammatory mechanism of resveratrol in activated HMC-1 cells: pivotal roles of NF-κB and MAPK. Pharmacol Res 59: 330-337, 2009.
28. Seow CJ, Chue SC and Wong WS: Piceatannol, a syk-selective tyrosine kinase inhibitor, attenuated antigen challenge of guinea pig airway in vitro. Eur J Pharmacol 443: 189-196, 2002.
29. Park HH, Lee SY, Son HY, et al: Flavonoids inhibit histamine release and expression of proinflammatory cytokine in mast cells. Arch Pharm Res 31: 1303-1311, 2008.
30. Kemp SF and Lockey RF: Anaphylaxis: a review of causes and mechanisms. J Allergy Clin Immunol 110: 341-348, 2002.
31. Jutel M, Blaser K and Akdis CA: Histamine in allergic inflammation and immune modulation. Int Arch Allergy Immunol 137: 82-92, 2005.
32. Jutel M, Watanabe T, Akdis M, Blaser K and Akdis CA: Immune regulation by histamine. Curr Opin Immunol 14: 735-740, 2002.
33. Matsuda H, Tewtrakul S, Morikawa T and Yoshikawa M: Anti-allergic activity of stilbenes from Korean rhubarb (Rheum undulatum L.): structure requirements for inhibition of antigen-induced degranulation and their effects on the release of TNF-alpha and IL-4 in RBL-2H3 cells. Bioorg Med Chem 12: 4871-4876, 2004.
34. Hu ZQ, Zhao WH and Shimamura T: Regulation of mast cell development by inflammatory factors. Curr Med Chem 14: 3044-3050, 2007.
35. Galli SJ, Kalesnikoff J, Grimbaldeston MA, Piliponsky AM, Williams CM and Tsai M: Mast cells as 'tunable' effector and immunoregulatory cells: recent advances. Annu Rev Immunol 23: 749-786, 2005.
36. Hu ZQ, Kobayashi K, Zenda N and Shimamura T: Tumor necrosis factor alpha and interleukin-6 triggered mast cell development from mouse spleen cells. Blood 89: 526-533, 1997.
37. Burd PR, Rogers HW, Gordon JR, et al: Interleukin 3-dependent and independent mast cells stimulated with IgE and antigen express multiple cytokines. J Exp Med 170: 245-257, 1989.
38. Arbabi S and Maier RV: Mitogen-activated protein kinases. Crit Care Med 30: S74-S79, 2002.
39. Ashikawa K, Majumdar S, Banerjee S, Bharti AC, Shishodia S and Aggarwal BB: Piceatannol inhibits TNF-induced NF-kappaB activation and NF-kappaB-mediated gene expression through suppression of IkappaBalpha kinase and p65 phosphorylation. J Immunol 169: 6490-6497, 2002.